Gliadel

DRUG2 trials

Sponsors

Eisai Inc., Duke University

Conditions

Glioblastoma MultiformeGliosarcomaMetastatic Brain Cancer

Phase 2

Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

CompletedNCT00525590

Eisai Inc.Metastatic Brain Cancer

Start: 2007-12-12End: 2010-12-01Updated: 2020-03-16

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

TerminatedNCT01186406

Duke UniversityGlioblastoma Multiforme, Gliosarcoma

Start: 2011-04-30End: 2014-06-16Updated: 2019-02-15